Physician profile
Charles L Hageman
NPI 1790781862
$1,017.27
in general payments reported to CMS, 2019-2025
16 companies · $37.48 in 2025
The $37.48 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $194 · 2021: $192 · 2022: $26.50 · 2025: $37.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $255.89 | 2019-2021 | |
| Therapeuticsmd, INC. | $188.45 | 2019-2021 | |
| Coopersurgical, INC. | $81.25 | 2019-2021 | |
| Hologic Sales and Service, LLC | $80.74 | 2019-2020 | |
| Baxter Healthcare | $63.98 | 2022-2025 | Perclot, Tisseel |
| Merck Sharp & Dohme LLC | $56.55 | 2019-2021 | |
| Astellas Pharma US INC | $54.50 | 2019-2021 | |
| Lupin INC. | $53.21 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.06 | 2019 | |
| Novo Nordisk INC | $34.11 | 2019-2021 | |
| Pfizer INC. | $24.06 | 2019-2021 | |
| Medtronic Minimed, INC. | $18.18 | 2019 | |
| Allergan, INC. | $17.67 | 2020 | |
| Amgen INC. | $16.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.05 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hageman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.